Regencell Bioscience Holdings Limited (RGC)

NASDAQ: RGC · Real-Time Price · USD

5.72

+0.10 (1.78%)

At close: Jul 24, 2026, 4:00 PM EDT

5.95

+0.23 (4.02%)

Pre-market: Jul 27, 2026, 4:35 AM EDT

RGC Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	2.36	2.42	2.96	1.56	6.42	0.06
Short-Term Investments	-	2.48	5	10	10	-
Cash & Short-Term Investments	2.36	4.9	7.96	11.56	16.42	0.06
Cash Growth	-51.86%	-38.49%	-31.16%	-29.56%	27532.00%	-84.65%
Other Current Assets	-	0.01	0.15	0.06	0.03	0.01
Total Current Assets	2.36	4.9	8.11	11.62	16.44	0.07
Net Property, Plant & Equipment	0.56	0.76	0.23	0.89	1.46	0.08
Other Long-Term Assets	0.09	0.09	0.1	0.11	0.11	0.19
Total Assets	3.01	5.76	8.44	12.62	18.02	0.34

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Accrued Expenses	1.41	0.35	0.13	0.16	0.15	0.57
Short-Term Debt	-	-	-	-	-	3.68
Current Portion of Leases	0.26	0.31	0.06	0.44	0.41	-
Other Current Liabilities	0	0	0.01	0.01	0.02	0.08
Total Current Liabilities	1.67	0.66	0.19	0.61	0.58	4.34
Long-Term Leases	0.13	0.23	0.03	0.03	0.36	-
Total Long-Term Liabilities	0.13	0.23	0.03	0.03	0.36	-
Total Liabilities	1.79	0.9	0.22	0.63	0.94	4.34

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	31.76	30.12	29.88	29.43	28.51	0
Accumulated Other Comprehensive Income	-0.02	-0.06	-0.05	-0.09	-	-
Retained Earnings	-30.52	-25.2	-21.62	-17.32	-11.44	-4
Total Common Shareholders' Equity	1.22	4.86	8.22	12.03	17.07	-4
Minority Interest	-	-	-	-0.04	0.02	-
Shareholders' Equity	1.22	4.86	8.22	11.99	17.08	-4
Total Liabilities & Equity	3.01	5.76	8.44	12.62	18.02	0.34

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Total Debt	0.39	0.54	0.09	0.46	0.77	3.68
Net Cash (Debt)	1.97	4.35	7.88	11.1	15.65	-3.62
Net Cash Growth	-54.72%	-44.73%	-29.06%	-29.05%	-	-
Net Cash Per Share	0.00	0.01	0.02	0.02	0.03	-0.01
Book Value	1.22	4.86	8.22	12.03	17.07	-4
Book Value Per Share	0.00	0.01	0.02	0.02	0.04	-0.01
Tangible Book Value	1.22	4.86	8.22	12.03	17.07	-4
Tangible Book Value Per Share	0.00	0.01	0.02	0.02	0.04	-0.01

SEC Filings: 10-K · 10-Q